HEADER HYDROLASE 24-AUG-06 2I5I TITLE CRYSTAL STRUCTURE OF A PUTATIVE CELLOBIOSE-PHOSPHATE CLEAVAGE PROTEIN TITLE 2 (EF3048) FROM ENTEROCOCCUS FAECALIS V583 AT 1.70 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UPF0249 PROTEIN EF_3048; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECALIS; SOURCE 3 ORGANISM_TAXID: 226185; SOURCE 4 STRAIN: V583; SOURCE 5 GENE: EF3048; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS PUTATIVE CELLOBIOSE-PHOSPHATE CLEAVAGE PROTEIN, STRUCTURAL GENOMICS, KEYWDS 2 JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, PSI-2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 7 25-JAN-23 2I5I 1 SEQADV LINK REVDAT 6 25-OCT-17 2I5I 1 REMARK REVDAT 5 18-OCT-17 2I5I 1 REMARK REVDAT 4 13-JUL-11 2I5I 1 VERSN REVDAT 3 28-JUL-10 2I5I 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2I5I 1 VERSN REVDAT 1 05-SEP-06 2I5I 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (EF3048) FROM JRNL TITL 2 ENTEROCOCCUS FAECALIS V583 AT 1.70 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELX REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.146 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.144 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2883 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 59414 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.139 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.137 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.179 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2615 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 52592 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 363 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4426.4 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 3978.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 3 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 17818 REMARK 3 NUMBER OF RESTRAINTS : 22295 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 ANGLE DISTANCES (A) : 0.024 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.049 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.027 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.040 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.044 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.017 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.052 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. NCS RESTRAINTS WERE APPLIED BETWEEN RESIDUES 2-262 REMARK 3 OF CHAINS A AND B. REMARK 3 3. REFINEMENT WAS AGAINST INTENSITY DATA. REMARK 3 4. REFINEMENT WAS CARRIED WITH THE TWIN LAW OF [K,H,-L] WITH REMARK 3 THE TWIN FRACTION OF 0.3513. THE RFREE DECREASES FROM 0.27 TO REMARK 3 0.1888. REMARK 3 5. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION REMARK 3 DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE REMARK 3 RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING REMARK 3 POWER DUE TO PARTIAL S-MET INCORPORATION. REMARK 4 REMARK 4 2I5I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039162. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918370,0.978981,0.979291 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59414 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 29.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.50500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40.0% MPD, 0.1M HEPES PH 7.0, VAPOR REMARK 280 DIFFUSION,SITTING DROP,NANODROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 65.26500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.68077 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.58667 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 65.26500 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 37.68077 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 28.58667 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 65.26500 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 37.68077 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.58667 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 75.36153 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 57.17333 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 75.36153 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 57.17333 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 75.36153 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 57.17333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC REMARK 300 UNIT WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 REMARK 300 FOR INFORMATION ON GENERATING THE BIOLOGICAL REMARK 300 MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT REMARK 300 OF A HEXAMER AS THE BIOLOGICALLY SIGNIFICANT REMARK 300 OLIGIMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 53790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -64.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 65.26500 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 113.04230 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -65.26500 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 113.04230 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 379 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 397 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 408 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 2 OG REMARK 470 GLN A 93 CD OE1 NE2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 GLU A 103 CG CD OE1 OE2 REMARK 470 LYS A 138 CE NZ REMARK 470 ILE A 161 CG2 CD1 REMARK 470 GLU A 162 CG CD OE1 OE2 REMARK 470 LYS A 164 CG CD CE NZ REMARK 470 GLU A 178 CG CD OE1 OE2 REMARK 470 LYS A 186 CE NZ REMARK 470 GLU A 191 CG CD OE1 OE2 REMARK 470 GLU A 204 CG CD OE1 OE2 REMARK 470 ARG A 233 CD NE CZ NH1 NH2 REMARK 470 GLU A 249 CD OE1 OE2 REMARK 470 SER B 2 CB OG REMARK 470 LYS B 5 CD CE NZ REMARK 470 GLU B 86 CG CD OE1 OE2 REMARK 470 LYS B 99 NZ REMARK 470 GLU B 103 CG CD OE1 OE2 REMARK 470 LYS B 138 CD CE NZ REMARK 470 ILE B 161 CG1 CG2 CD1 REMARK 470 LYS B 164 CD CE NZ REMARK 470 LYS B 186 CE NZ REMARK 470 GLU B 191 CG CD OE1 OE2 REMARK 470 GLN B 195 CD OE1 NE2 REMARK 470 GLU B 204 CG CD OE1 OE2 REMARK 470 GLU B 206 CD OE1 OE2 REMARK 470 ARG B 233 NE CZ NH1 NH2 REMARK 470 GLU B 242 CD OE1 OE2 REMARK 470 GLU B 248 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 116 CB - CG - CD1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG A 122 NE - CZ - NH1 ANGL. DEV. = 5.3 DEGREES REMARK 500 ARG A 122 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 HIS A 133 C - N - CA ANGL. DEV. = 15.1 DEGREES REMARK 500 HIS A 133 CA - CB - CG ANGL. DEV. = 11.3 DEGREES REMARK 500 ARG A 231 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 148 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG B 148 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 12 26.86 86.42 REMARK 500 THR A 67 14.13 -141.02 REMARK 500 GLN A 171 -105.90 59.36 REMARK 500 ASP A 185 -112.14 45.75 REMARK 500 CYS A 228 -78.44 -122.92 REMARK 500 ASP B 12 23.10 87.54 REMARK 500 ALA B 55 56.87 -142.78 REMARK 500 GLN B 171 -109.39 60.04 REMARK 500 ASP B 185 -115.05 48.53 REMARK 500 CYS B 228 -78.33 -130.66 REMARK 500 CYS B 228 -78.46 -130.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 359291 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION REMARK 999 TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET REMARK 999 SEQUENCE. DBREF 2I5I A 1 262 UNP P59745 Y3048_ENTFA 1 262 DBREF 2I5I B 1 262 UNP P59745 Y3048_ENTFA 1 262 SEQADV 2I5I GLY A 0 UNP P59745 EXPRESSION TAG SEQADV 2I5I MSE A 1 UNP P59745 MET 1 MODIFIED RESIDUE SEQADV 2I5I MSE A 48 UNP P59745 MET 48 MODIFIED RESIDUE SEQADV 2I5I MSE A 79 UNP P59745 MET 79 MODIFIED RESIDUE SEQADV 2I5I MSE A 117 UNP P59745 MET 117 MODIFIED RESIDUE SEQADV 2I5I MSE A 179 UNP P59745 MET 179 MODIFIED RESIDUE SEQADV 2I5I MSE A 199 UNP P59745 MET 199 MODIFIED RESIDUE SEQADV 2I5I MSE A 229 UNP P59745 MET 229 MODIFIED RESIDUE SEQADV 2I5I MSE A 262 UNP P59745 MET 262 MODIFIED RESIDUE SEQADV 2I5I GLY B 0 UNP P59745 EXPRESSION TAG SEQADV 2I5I MSE B 1 UNP P59745 MET 1 MODIFIED RESIDUE SEQADV 2I5I MSE B 48 UNP P59745 MET 48 MODIFIED RESIDUE SEQADV 2I5I MSE B 79 UNP P59745 MET 79 MODIFIED RESIDUE SEQADV 2I5I MSE B 117 UNP P59745 MET 117 MODIFIED RESIDUE SEQADV 2I5I MSE B 179 UNP P59745 MET 179 MODIFIED RESIDUE SEQADV 2I5I MSE B 199 UNP P59745 MET 199 MODIFIED RESIDUE SEQADV 2I5I MSE B 229 UNP P59745 MET 229 MODIFIED RESIDUE SEQADV 2I5I MSE B 262 UNP P59745 MET 262 MODIFIED RESIDUE SEQRES 1 A 263 GLY MSE SER ASN LYS LYS LEU ILE ILE ASN ALA ASP ASP SEQRES 2 A 263 PHE GLY TYR THR PRO ALA VAL THR GLN GLY ILE ILE GLU SEQRES 3 A 263 ALA HIS LYS ARG GLY VAL VAL THR SER THR THR ALA LEU SEQRES 4 A 263 PRO THR SER PRO TYR PHE LEU GLU ALA MSE GLU SER ALA SEQRES 5 A 263 ARG ILE SER ALA PRO THR LEU ALA ILE GLY VAL HIS LEU SEQRES 6 A 263 THR LEU THR LEU ASN GLN ALA LYS PRO ILE LEU PRO ARG SEQRES 7 A 263 GLU MSE VAL PRO SER LEU VAL ASP GLU ALA GLY TYR PHE SEQRES 8 A 263 TRP HIS GLN SER ILE PHE GLU GLU LYS VAL ASN LEU GLU SEQRES 9 A 263 GLU VAL TYR ASN GLU TRP ASP ALA GLN ILE ILE SER PHE SEQRES 10 A 263 MSE LYS SER GLY ARG ARG PRO ASP HIS ILE ASP SER HIS SEQRES 11 A 263 HIS ASN VAL HIS GLY LYS ASN LYS LYS LEU LEU GLY VAL SEQRES 12 A 263 ALA LEU ALA LEU ALA ARG LYS TYR GLN LEU PRO LEU ARG SEQRES 13 A 263 ASN ALA SER ARG SER ILE GLU THR LYS ASP TYR LEU GLU SEQRES 14 A 263 LEU TYR GLN ASP VAL ARG THR PRO ASP GLU MSE LEU TYR SEQRES 15 A 263 GLN PHE TYR ASP LYS ALA ILE SER THR GLU THR ILE LEU SEQRES 16 A 263 GLN LEU LEU ASP MSE VAL VAL CYS SER GLU GLY GLU VAL SEQRES 17 A 263 PHE GLU ILE ASN CYS HIS PRO ALA PHE ILE ASP THR ILE SEQRES 18 A 263 LEU GLN ASN GLN SER GLY TYR CYS MSE PRO ARG ILE ARG SEQRES 19 A 263 GLU VAL GLU ILE LEU THR SER GLN GLU VAL LYS GLU ALA SEQRES 20 A 263 ILE GLU GLU ARG GLY ILE LEU LEU ALA ASN TYR GLU SER SEQRES 21 A 263 LEU ALA MSE SEQRES 1 B 263 GLY MSE SER ASN LYS LYS LEU ILE ILE ASN ALA ASP ASP SEQRES 2 B 263 PHE GLY TYR THR PRO ALA VAL THR GLN GLY ILE ILE GLU SEQRES 3 B 263 ALA HIS LYS ARG GLY VAL VAL THR SER THR THR ALA LEU SEQRES 4 B 263 PRO THR SER PRO TYR PHE LEU GLU ALA MSE GLU SER ALA SEQRES 5 B 263 ARG ILE SER ALA PRO THR LEU ALA ILE GLY VAL HIS LEU SEQRES 6 B 263 THR LEU THR LEU ASN GLN ALA LYS PRO ILE LEU PRO ARG SEQRES 7 B 263 GLU MSE VAL PRO SER LEU VAL ASP GLU ALA GLY TYR PHE SEQRES 8 B 263 TRP HIS GLN SER ILE PHE GLU GLU LYS VAL ASN LEU GLU SEQRES 9 B 263 GLU VAL TYR ASN GLU TRP ASP ALA GLN ILE ILE SER PHE SEQRES 10 B 263 MSE LYS SER GLY ARG ARG PRO ASP HIS ILE ASP SER HIS SEQRES 11 B 263 HIS ASN VAL HIS GLY LYS ASN LYS LYS LEU LEU GLY VAL SEQRES 12 B 263 ALA LEU ALA LEU ALA ARG LYS TYR GLN LEU PRO LEU ARG SEQRES 13 B 263 ASN ALA SER ARG SER ILE GLU THR LYS ASP TYR LEU GLU SEQRES 14 B 263 LEU TYR GLN ASP VAL ARG THR PRO ASP GLU MSE LEU TYR SEQRES 15 B 263 GLN PHE TYR ASP LYS ALA ILE SER THR GLU THR ILE LEU SEQRES 16 B 263 GLN LEU LEU ASP MSE VAL VAL CYS SER GLU GLY GLU VAL SEQRES 17 B 263 PHE GLU ILE ASN CYS HIS PRO ALA PHE ILE ASP THR ILE SEQRES 18 B 263 LEU GLN ASN GLN SER GLY TYR CYS MSE PRO ARG ILE ARG SEQRES 19 B 263 GLU VAL GLU ILE LEU THR SER GLN GLU VAL LYS GLU ALA SEQRES 20 B 263 ILE GLU GLU ARG GLY ILE LEU LEU ALA ASN TYR GLU SER SEQRES 21 B 263 LEU ALA MSE MODRES 2I5I MSE A 48 MET SELENOMETHIONINE MODRES 2I5I MSE A 79 MET SELENOMETHIONINE MODRES 2I5I MSE A 117 MET SELENOMETHIONINE MODRES 2I5I MSE A 179 MET SELENOMETHIONINE MODRES 2I5I MSE A 199 MET SELENOMETHIONINE MODRES 2I5I MSE A 229 MET SELENOMETHIONINE MODRES 2I5I MSE A 262 MET SELENOMETHIONINE MODRES 2I5I MSE B 48 MET SELENOMETHIONINE MODRES 2I5I MSE B 79 MET SELENOMETHIONINE MODRES 2I5I MSE B 117 MET SELENOMETHIONINE MODRES 2I5I MSE B 179 MET SELENOMETHIONINE MODRES 2I5I MSE B 199 MET SELENOMETHIONINE MODRES 2I5I MSE B 229 MET SELENOMETHIONINE MODRES 2I5I MSE B 262 MET SELENOMETHIONINE HET MSE A 48 8 HET MSE A 79 8 HET MSE A 117 8 HET MSE A 179 8 HET MSE A 199 8 HET MSE A 229 8 HET MSE A 262 9 HET MSE B 48 8 HET MSE B 79 8 HET MSE B 117 8 HET MSE B 179 8 HET MSE B 199 8 HET MSE B 229 16 HET MSE B 262 9 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 3 HOH *363(H2 O) HELIX 1 1 THR A 16 ARG A 29 1 14 HELIX 2 2 TYR A 43 ALA A 55 1 13 HELIX 3 3 VAL A 80 VAL A 84 5 5 HELIX 4 4 HIS A 92 GLU A 97 1 6 HELIX 5 5 ASN A 101 MSE A 117 1 17 HELIX 6 6 LYS A 118 GLY A 120 5 3 HELIX 7 7 HIS A 130 LYS A 135 5 6 HELIX 8 8 ASN A 136 GLN A 151 1 16 HELIX 9 9 SER A 160 TYR A 170 5 11 HELIX 10 10 TYR A 184 ILE A 188 5 5 HELIX 11 11 SER A 189 SER A 203 1 15 HELIX 12 12 ASP A 218 SER A 225 1 8 HELIX 13 13 MSE A 229 THR A 239 1 11 HELIX 14 14 SER A 240 ARG A 250 1 11 HELIX 15 15 ASN A 256 ALA A 261 5 6 HELIX 16 16 THR B 16 ARG B 29 1 14 HELIX 17 17 TYR B 43 ALA B 55 1 13 HELIX 18 18 VAL B 80 VAL B 84 5 5 HELIX 19 19 ILE B 95 LYS B 99 5 5 HELIX 20 20 ASN B 101 MSE B 117 1 17 HELIX 21 21 LYS B 118 GLY B 120 5 3 HELIX 22 22 HIS B 130 LYS B 135 5 6 HELIX 23 23 ASN B 136 GLN B 151 1 16 HELIX 24 24 SER B 160 TYR B 170 5 11 HELIX 25 25 TYR B 184 ILE B 188 5 5 HELIX 26 26 SER B 189 SER B 203 1 15 HELIX 27 27 ASP B 218 SER B 225 1 8 HELIX 28 28 MSE B 229 SER B 240 1 12 HELIX 29 29 SER B 240 ARG B 250 1 11 HELIX 30 30 ASN B 256 ALA B 261 5 6 SHEET 1 A 6 ILE A 126 SER A 128 0 SHEET 2 A 6 ALA A 59 LEU A 64 1 N LEU A 64 O ASP A 127 SHEET 3 A 6 SER A 34 ALA A 37 1 N ALA A 37 O HIS A 63 SHEET 4 A 6 LYS A 5 PHE A 13 1 N ALA A 10 O SER A 34 SHEET 5 A 6 VAL A 207 CYS A 212 1 O PHE A 208 N LYS A 5 SHEET 6 A 6 GLU A 178 LEU A 180 1 N LEU A 180 O GLU A 209 SHEET 1 B 5 ILE A 126 SER A 128 0 SHEET 2 B 5 ALA A 59 LEU A 64 1 N LEU A 64 O ASP A 127 SHEET 3 B 5 SER A 34 ALA A 37 1 N ALA A 37 O HIS A 63 SHEET 4 B 5 LYS A 5 PHE A 13 1 N ALA A 10 O SER A 34 SHEET 5 B 5 LEU A 253 ALA A 255 1 O LEU A 253 N LEU A 6 SHEET 1 C 6 ILE B 126 SER B 128 0 SHEET 2 C 6 ALA B 59 LEU B 64 1 N LEU B 64 O ASP B 127 SHEET 3 C 6 SER B 34 ALA B 37 1 N ALA B 37 O HIS B 63 SHEET 4 C 6 LYS B 4 PHE B 13 1 N ALA B 10 O SER B 34 SHEET 5 C 6 VAL B 207 CYS B 212 1 O ILE B 210 N ILE B 7 SHEET 6 C 6 GLU B 178 LEU B 180 1 N LEU B 180 O GLU B 209 SHEET 1 D 5 ILE B 126 SER B 128 0 SHEET 2 D 5 ALA B 59 LEU B 64 1 N LEU B 64 O ASP B 127 SHEET 3 D 5 SER B 34 ALA B 37 1 N ALA B 37 O HIS B 63 SHEET 4 D 5 LYS B 4 PHE B 13 1 N ALA B 10 O SER B 34 SHEET 5 D 5 ILE B 252 ALA B 255 1 O LEU B 253 N LEU B 6 LINK C ALA A 47 N MSE A 48 1555 1555 1.34 LINK C MSE A 48 N GLU A 49 1555 1555 1.34 LINK C GLU A 78 N MSE A 79 1555 1555 1.33 LINK C MSE A 79 N VAL A 80 1555 1555 1.33 LINK C PHE A 116 N MSE A 117 1555 1555 1.33 LINK C MSE A 117 N LYS A 118 1555 1555 1.32 LINK C GLU A 178 N MSE A 179 1555 1555 1.32 LINK C MSE A 179 N LEU A 180 1555 1555 1.33 LINK C ASP A 198 N MSE A 199 1555 1555 1.33 LINK C MSE A 199 N VAL A 200 1555 1555 1.34 LINK C CYS A 228 N MSE A 229 1555 1555 1.34 LINK C MSE A 229 N PRO A 230 1555 1555 1.32 LINK C ALA A 261 N MSE A 262 1555 1555 1.31 LINK C ALA B 47 N MSE B 48 1555 1555 1.34 LINK C MSE B 48 N GLU B 49 1555 1555 1.34 LINK C GLU B 78 N MSE B 79 1555 1555 1.34 LINK C MSE B 79 N VAL B 80 1555 1555 1.34 LINK C PHE B 116 N MSE B 117 1555 1555 1.33 LINK C MSE B 117 N LYS B 118 1555 1555 1.33 LINK C GLU B 178 N MSE B 179 1555 1555 1.33 LINK C MSE B 179 N LEU B 180 1555 1555 1.33 LINK C ASP B 198 N MSE B 199 1555 1555 1.33 LINK C MSE B 199 N VAL B 200 1555 1555 1.33 LINK C CYS B 228 N BMSE B 229 1555 1555 1.34 LINK C CYS B 228 N AMSE B 229 1555 1555 1.33 LINK C BMSE B 229 N PRO B 230 1555 1555 1.33 LINK C AMSE B 229 N PRO B 230 1555 1555 1.33 LINK C ALA B 261 N MSE B 262 1555 1555 1.30 CRYST1 130.530 130.530 85.760 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007660 0.004420 0.000000 0.00000 SCALE2 0.000000 0.008850 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011660 0.00000